Publication: Cost-effectiveness analysis and safety of erythromycin 4% gel and 4% chlorhexidine scrub for pitted keratolysis treatment
Issued Date
2019-08-18
Resource Type
ISSN
14711753
09546634
09546634
Other identifier(s)
2-s2.0-85058232479
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Dermatological Treatment. Vol.30, No.6 (2019), 627-629
Suggested Citation
Charussri Leeyaphan, Sumanas Bunyaratavej, Suthira Taychakhoonavudh, Nattanichcha Kulthanachairojana, Penvadee Pattanaprichakul, Pattriya Chanyachailert, Punyawee Ongsri, Sittiroj Arunkajohnsak, Pichaya Limphoka, Kanokvalai Kulthanan Cost-effectiveness analysis and safety of erythromycin 4% gel and 4% chlorhexidine scrub for pitted keratolysis treatment. Journal of Dermatological Treatment. Vol.30, No.6 (2019), 627-629. doi:10.1080/09546634.2018.1543846 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/51463
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Cost-effectiveness analysis and safety of erythromycin 4% gel and 4% chlorhexidine scrub for pitted keratolysis treatment
Abstract
© 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group. Background: Studies of Pitted keratolysis (PK) treatment are limited. Objectives: To study cost-effectiveness and to compare the safety of 4% chlorhexidine scrub with 4% erythromycin gel, for PK infections. Materials and methods: This cohort study was conducted on naval rating cadets with a clinical diagnosis of PK at Chumpol Naval Rating School, Thailand in 2016. Participants were randomly treated with either 4% erythromycin gel or 4% chlorhexidine scrub for 4 weeks. The clinical examinations were evaluated at the baseline and at 1 and 2 months after treatment. A decision-tree model was used to evaluate the costs, resource utilization and outcomes as quality-adjusted life-years (QALYs). Results: Of 344 naval rating cadets, 125 (36.3%) were diagnosed with PK. Sixty-four were treated with erythromycin. Approximately 80% of participants had complete resolution Foot odor were significantly improved at 2 months (p <.001) for both groups. No adverse effects were reported. Total cost for 4 weeks’ treatment with the erythromycin gel and chlorhexidine scrub was US$77.34, US$51.9, respectively. Chlorhexidine treatment and erythromycin gel had 0.1526 and 0.1425 QALYs, respectively. Conclusions: treatment of PK with either 4% chlorhexidine scrub or 4% erythromycin gel had similar outcomes. However, using chlorhexidine scrub was more cost-effective.